Search
Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus.
A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy.
Leaders from both institutions announced their collaboration and shared details about what it can mean for people with cancer in the state and throughout the world.
Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.
Find out what Memorial Sloan Kettering experts recommend when it comes to marijuana, CBD, and other forms of cannabis for cancer.
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.
Across the United States, there is a disparity in the rate of people who are candidates for a partial nephrectomy — those with small renal tumors — and those who actually have the procedure.
Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.
New MSK research uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing.